VYNE
VYNE Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD0.65
+0.00 (+0.39%)
Rating:C+
Company Profile
CEO
David T. Domzalski
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$0.65
Prev. Close
$0.65
Day Low
$0.65
Day High
$0.66
52W Low
$0.28
52W High
$1.96
Market Cap
$0.01B
Volume
0.01M